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Abstract.  Apoptosis is the predominant form of cell 
death and occurs under a variety of physiological and 
pathological conditions.  Cells undergoing apoptotic 
cell death reveal a characteristic  sequence of cytologi- 
cal alterations  including  membrane blebbing and nu- 
clear and cytoplasmic condensation.  Activation of an 
endonuclease which cleaves genomic DNA into inter- 
nucleosomal DNA fragments is considered to be the 
hallmark of apoptosis.  However, no clear evidence ex- 
ists that DNA degradation plays a primary and causa- 
tive role in apoptotic cell death.  Here we show that 
cells enucleated with cytochalasin B  still undergo 
apoptosis induced either by treatment with menadione, 
an oxidant quinone compound, or by triggering 
APO-1/Fas, a cell surface molecule involved in physio- 
logical cell death.  Incubation of enucleated cells with 
the agonistic monoclonal anti-APO-1  antibody re- 
vealed the key morphological features of apoptosis. 
Moreover, in non-enucleated cells inhibitors of en- 
donuclease blocked DNA fragmentation,  but not cell 
death induced by anti-APO-1.  These data suggest that 
DNA degradation and nuclear signaling  are not re- 
quired for induction of apoptotic cell death. 
OPTOSIS, the most common form of physiological cell 
death, occurs during embryonic development,  tissue 
remodeling,  and tumor regression (1, 28). Apoptosis 
plays an important role in the immune system as a mecha- 
nism of selective depletion of autoreactive T cells during 
clonal selection (5, 10). Cells undergoing  apoptosis show a 
sequence of cardinal morphological features including mem- 
brane blebbing, cellular  shrinkage,  and condensation  and 
margination  of chromatin  (1, 28). In contrast to necrotic cell 
death which mainly occurs following traumatic  injury, mito- 
chondria and other cytoplasmic organelles  remain intact in 
early stages of apoptosis. BiochemicaUy,  these alterations 
are associated with the cleavage of genomic DNA into multi- 
ples  of internucleosomal  180-bp  fragments,  which  upon 
agarose gel electrophoresis give rise to a characteristic  DNA 
ladder (36). This internucleosomal DNA digestion is consid- 
ered to arise from the activation  of an endonuclease whose 
identity  is still controversial  (2, 23, 24). 
Apoptosis can be initiated  by various pathological  and 
physiological  inducers  such  as  corticoids,  quinone  com- 
pounds,  ionizing  irradiation,  triggering  of cytokine recep- 
tors and deprivation of growth factors. Important physiologi- 
cal  mediators  of  apoptosis  are  members  of  the  tumor 
necrosis factor (TNF)l/nerve growth factor (NGF) recep- 
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tor superfamily  including  TNF RI (14), TNF RII (31), the 
APO-1/Fas receptor (12, 22), the low affinity NGF receptor 
(27),  and the B cell antigen CD40 (32).  It has been shown 
that binding of the ligand or agonistic antibodies to the TNF 
receptors or to APO-1/Fas  induces apoptotic cell death in 
various cell types, whereas the NGF receptor and CD40 ap- 
parently transmit  a constitutive  death signal that is blocked 
upon binding  of their ligands  (26, 34). 
Since endonuclease activation is one of the earliest events 
observed during  apoptosis,  it  is  generally  assumed  that 
apeptosis depends on nuclear signaling and the activation of 
an  endonuclease.  Endonucleolytic DNA fragmentation  is 
considered the hallmark of apoptosis that is frequently used 
as the sole criterion for its detection (1, 5, 10, 28). However, 
no clear evidence has been presented so far that DNA degra- 
dation plays a primary and causative role in apoptotic cell 
death.  In contrast,  recent reports have described that  cell 
death with key morphological features  of apoptosis can be 
induced in the absence of detectable DNA fragmentation  (4, 
9, 20, 30). 
In this  study we show that apoptosis, induced by anti- 
APO-1 and the oxidant compound menadione,  can be also 
induced in enucleated cells.  In addition,  it is demonstrated 
that selective DNA degradation  is neither sufficient nor nec- 
essary for apoptotic cell death.  Our results therefore suggest 
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for the initiation of apoptotic events. 
Materials and Methods 
Cells and Reagents 
L929-APO-1  cells were derived from the murine fibrosarcoma cell line 
L929 after stable transfection with pEX-APO-I, an expression plasmid cod- 
ing for human APO-1/Fas (22, 29).  Cells were grown in RPMI-1640  sup- 
plemented with 10% hcat-inactivated  fetal calf serum, 100 units of penicil- 
lin/ml and 0.1 nag streptomycin/ml.  Expression of APO-1/Fas was verified 
by fluorescence  immunochemistry and sensitivity towards  the cytotoxic 
effects of anti-APO-1  (29). Anti-APO-1 monoclonal antibody (mouse IgG3) 
has been described in (34)  and was used after purification  by protein A 
affinity chromatography. 
Enucleation of Cells 
L929-APO-1  cells  were  enucleated  essentially  as  described  (19, 25). 
Briefly, 2  x  106 cells were seeded in 25 cm  2 tissue flasks.  12 h later, the 
medium was exchanged  against serum-free medium containing 10 ~g/ml 
cytochalasin B (Sigma Chem. Co., Deisenhofen, FRG). For enucleation, 
cells were incubated for 90 min in the presence of cytochalasin B and then 
centrifuged inside the flasks in a Sorvall GSA rotor at 37°C and 25,000 g 
for 50 rain. After centrifugation,  cells were allowed to recover for 2 h in 
serum-containing medium without cytochalasin B and then treated with 
anti-APO-1  or menadione (Sigma  Chem. Co.).  Non-enucleated controls 
were treated with cytochaiasin B without subsequent centrifugation. 
Light Microscopy 
Cells were washed twice with PBS and fixed in ice-cold methanol/ethanol 
(1:1) for 1 h. Fixed cells were stained for 30 min with propidium iodide (1 
#g/ml) in PBS containing 0.1 mg/ml RNAse. The specimens were analyzed 
under phase contrast and fluorescent light using a Zeiss Axiovert 35 micro- 
scope. 
Electron Microscopy 
L929-APO-1  cells were grown on THERMANOX coverslips (Nunc, W'les- 
baden, FRG) and enuclcated in Sorvull tubes similarly as described above. 
Cells were fixed with 2.5% glutaraldehyde  for 15 min in 50 mM cacodylate 
buffer, pH 7.4,  containing 50 mM KCI and 2.5 mM MgC12. After three 
washing steps in buffer, cells were postiixed for 2 h with 2 % osmium tetrox- 
ide in 25 mM plain cacodylate buffer and block-stained  overnight  with 0.5 % 
uranyl acetate in water.  Embedding and all other procedures were per- 
formed  essentially  as described (7). 
Cytotoxicity Assays 
Following enucleation, cells were treated with the indicated concentrations 
of anti-APO-1  or menadione in the presence or absence of actinomycin D 
(1 ~g/ml). After 12 h, cells were stained with crystal violet or MTT (3-4,5- 
dimethylthiazol-2yl)-2,5Miphenyltetrazolium  bromide) (18). The resulting 
formazan product was solubilized in 0.1% sodium dodecylsulphate,  10 mM 
HCI and measured spectrophotometrically at 540 nM. 
Gel Electrophoresis  of  Fragmented  DNA 
Cells were  seeded  in 6-well plates at 1.5  x  106 cells/well.  3 h later,  the 
Figure  1.  Apoptotic  altera- 
tions  induced by anti-APO-1 
antibodies  in  L929-APO-1 
cells.  2  x  106  L929-APO-1 
cells were  seeded in 25 cm  2- 
tissue culture flasks; 12 h later 
cells  were  treated  with  1.5 
/~g/ml anti-APO-l.  Following 
45  min of further incubation 
cells were processed for eval- 
uation by phase-contrast and 
fluorescence  microscopy.  (A 
and  B)  nontreated  cells;  (C 
and  D)  anti-APO-l-treated 
cells:  (C)  arrows  mark cells 
showing  membrane  blebbing 
and  cytoplasmic  condensa- 
tion;  (D)  several cells reveal 
condensed  nuclei.  Bars, 
20 #m. 
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boxylic acid (ATA) (Sigma Chem. Co.) and then further incubated with 
1.5 ~tg/ml anti-APO-1. For analysis of genomic DNA, cells were gently 
scraped  off  and collected  together  with the nonattached  cells  in the superna- 
tant. Cells were lysed in NTE buffer (100 mM NaCI, 40 mM Tris-HCI, 
20 told EDTA, pH 7.4) containing 0.5% SDS and 0.2 mg/ml  proteinase  K. 
After overnight  incubation at 37"C, DNA was extracted  twice  with  phenol- 
chloroform and precipitated by ethanol. Samples were dissolved in TE 
buffer and digested for 2 h with 0.1 mg/ml  RNAse A. DNA fragmentation 
was analyzed  on a 1.8% agarose  gel in the presence  of 0.5 tzg/ml ethidium 
bromide. 
Results and Discussion 
The requirement of DNA degradation for apoptosis was in- 
vestigated in murine  L929  fibrosarcoma cells.  L929  cells 
represent a suitable model for analyzing the functional role 
of DNA digestion  because  they  can  easily be enucleated 
upon  incubation  with  cytochalasin B  (19, 25,  38).  When 
L929-APO-1  cells,  stably  expressing  human  APO-1/Fas, 
were  treated  with  anti-APO-1  antibodies,  they  displayed 
characteristic features of apoptosis within 30 min. First mor- 
phological alterations included the appearance of membrane 
blebbing and cytoplasmic condensation (Fig. 1 C). This was 
followed by the condensation of nuclear chromatin, which 
was most pronounced within 2-6 h after cell treatment (Fig. 
1 D). Agarose gel electrophoresis further revealed extensive 
DNA digestion induced by anti-APO-1 (see Fig. 4 A). These 
events closely resembled apoptotic alterations  induced  by 
anti-APO-1 in other cell types (13, 34). To analyze whether 
typical apoptotic manifestations such as membrane blebbing 
and cytoplasmic condensation earl also be induced in the ab- 
sence of a cell nucleus, L929-APO-1 cells were enucleated. 
Cells were seeded in tissue flasks and treated with cytochala- 
sin B. 90 min later, nuclei were removed by high speed cen- 
trifugation of the tissue flasks. As assessed by DNA staining 
with the  karyophilic dye propidiurn  iodide this procedure 
resulted in enucleation of about 80-90% of the cells (Fig. 2, 
A and B). Measurement of succinate dehydrogenase activity 
further revealed that cell viability was not seriously affected 
within 30 h  after enucleation (data not shown).  When the 
cytoplasts were treated with anti-APO-1, 2 h after expulsion 
of the nuclei,  apoptotic alterations identical to the ones in 
ceils with nuclei were observed. Membrane blebbing was in- 
duced in enucleated cells within 30 min after anti-APO-1 
treatment as indicated by phase-contrast microscopy (Fig. 2 
C). In addition, the enucleated cells became condensed and 
phase-bright similarly as observed in non-enucleated parent 
cells. Parallel staining of nuclear chromatin with propidium 
iodide revealed that cells undergoing apoptosis were indeed 
devoid of a  nucleus  (Fig.  2 D). 
Apoptotic alterations in enucleated cells were also seen by 
electron microscopical analysis (Fig. 3, A and B). Cytoplasts 
treated with anti-APO-1 displayed vacuolization and mem- 
Figure  2.  Morphological 
changes  induced  by  anti- 
APO-1  in  enucleated  cells. 
L929-APO-1  cells  were 
seeded in tissue flasks as de- 
scribed in Fig. 1.12 h later the 
medium was exchanged a~inst 
serum-free  medium contain- 
ing  10 ttg/ml cytochalasin  B. 
For enucleation cells were in- 
cubated for 90 min in the pres- 
ence  of cytochalasin  B  and 
then centrifuged  at 37°C and 
25,000 g for 50 min. (AandB) 
untreated cells; (C and D) anti- 
APO-l-treated cells: (C) Enu- 
cleated  cells revealing  mem- 
brane blebbing and cytoplas- 
mic condensation are marked 
by an arrow. Bars, 20 t~m. 
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graphs  of cytoplasm treated 
with anti-APO-1. L929-APO-1 
cells  were grown on  cover- 
slips, enucleated, and treated 
with anti-APO-1 for 45 min. 
(A)  Overview of  cytoplasts 
demonstrating  the  onset  of 
membrane blebbing and cyto- 
plasmic  fragmentation.  (B) 
Higher magnification  of an in- 
dividual cytoplast demonstrat- 
ing vacuolization and exten- 
sive membrane  protrusions. 
Most membrane blebs contain 
swollen and dilated endoplas- 
mic reticulum. Note the intact 
mitochondrial ultrastructure. 
M,  mitochondrion;  V,  vacu- 
ole.  Bars: (A)  4  /~m; (B) 
2 ~m. 
brane-bound protrusions of the cytoplasm. The membrane 
blebs contained cytoplasmic material, ribosomes, and mostly 
dilated and swollen endoplasmic reticulum (Fig. 3 B). Typi- 
cally for early stages of  apoptosis, the ultrastructure of mito- 
chondria was not significantly altered. Later stages ended in 
the  complete  fragmentation  of  the  cytoplasm  (data  not 
shown). 
To analyze whether anti-APO-1  treatment induced cyto- 
toxic effects after enucleation, cells were stained for suc- 
cinate dehydrogenase activity, a known marker of mitochon- 
drial function and cell viability (18). Enucleated and control 
cells  (cells incubated with cytochalasin B  without subse- 
quent centrifugation) were treated for 12 h with anti-APO-1. 
As shown in Table I A, cell viability was markedly reduced 
Table  L  Cytotoxic Effects of Anti-APO-1  (A) and 
Menadione  (B) on Enucleated and Non-enucleated  Cells 
Cell Viability (ODin ~,,) Treatment 
Medium  Anti-APO- 1 
Control cells  1.18  4-  0.11  0.52  4-  0.09 
Control cells  +  Act D  0.97  4-  0.10  0.25  4-  0.06 
Enucleated cells  0.88  4- 0.15  0.34  4-  0.08 
Enucleated  cells  +  Act D  0.80  4-  0.13  0.31  4-  0.05 
B 
Trea~ent 
Medium  Menadione  Menadione 
25 ttM  100 #M 
Control cells  0.92  +  0.06  0.68  4-  0.09  0.20  4- 0.03 
Enucleated cells  0.78  4-  0.15  0.42  4-  0.03  0.16  4-  0.03 
L929-APO- 1 ceils were treated and enucleated as described in Fig. 2. Controls 
were incubated with cytoehalasin B but not enucleated by centrifugation.  Cells 
were treated for 12 h with 1.5 ttg/ml anti-APO-1 (,4) in the presence or absence 
of ! t~g/rnl  actinomycin D (Act D) or with the indicated concentrations of mena- 
dione (B). Cell viability was determined by staining with MTT and recorded 
spectrophotometrically at 540 nM. OD values are given as mean 5: SEM of tripli- 
cates from a representative experiment. 
by anti-APO-1  in non-enucleated and enucleated cells. In- 
terestingly,  the  transcriptional  inhibitor  actinomycin  D 
potentiated cytotoxicity of anti-APO-1  in control cells but 
not in cells devoid of a nucleus. 
Apoptosis can be induced by a variety of diverse agents. 
To investigate whether a cell nucleus was also not required 
for other forms of apoptosis, experiments with menadione 
were performed. Menadione is a quinone compound that un- 
dergoes redox cycling leading to continuous formation of su- 
peroxide anions (33).  Treatment with menadione has been 
shown to result in oxidative cell death resembling apoptosis 
(11,  16).  In L929-APO-1  ceils, apoptosis was induced by 
25-100 #M menadione within 12 h. As shown in Table I B, 
there  was  no  significant difference in  sensitivity towards 
menadione in enucleated and non-enucleated cells. There- 
fore, these observations clearly indicate that the presence of 
a nucleus and consequently endonucleolytic DNA degrada- 
tion is not required to transmit apoptotic signals. Both, mor- 
phological features of apoptosis and cytotoxic effects medi- 
ated  by  APO-1/Fas  or  by  the  oxidant  menadione  were 
observed in enucleated ceils. 
These conclusions were further supported by experiments 
with an endonuclease inhibitor.  A nonlysosomal CaWMg  ~+- 
dependent endonuclease assumed to be involved in apoptotic 
DNA cleavage is inhibited by zinc ions (6, 8) or ATA (17). 
Although the action of ATA is not specific, treatment with 
ATA may provide evidence for a dependency of cell killing 
on DNA  fragmentation. When ceils were incubated with 
anti-APOq,  agarose gel electrophoresis of genomic DNA 
revealed the typical DNA ladder composed of 180-bp  in- 
tegers (Fig. 4 A). Preincubation with 300/zM ATA followed 
by anti-APO-1 treatment inhibited the formation of a DNA 
ladder and fragmentation of DNA into  180-bp  multimers 
(Fig. 4 A), although it cannot be excluded that fragmentation 
of DNA into high molecular weight fragments (e.g., of 50 
kb) might still have occurred (21). However, under these con- 
ditions  APO-l-mediated  cytotoxicity as  assessed  by  cell 
morphology  and  viability  remained  virtually  unaffected 
(Fig. 4 B). Thus, inhibition of anti-APO-l-induced endonu- 
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the widely accepted dogma that internucleosonal DNA frag- 
mentation is a mandatory event for apoptotic cell death. The 
experiments  with  enucleated  cells  show that  induction  of 
apoptosis  must  involve  cytoplasmic  steps  rather  than  en- 
donuclease activation in the nucleus. 
Figure 4. The effect of the endonuclease inhibitor aurintricarboxylic 
acid (ATA) on anti-APO-l-induced  DNA fragmentation  (,4) and 
cell  survival  (B).  (,4) L929-APO-1  cells  were seeded  in 6-well 
plates at 1.5  x  106/well.  3 h later cells were either left untreated 
0aries 1 and 2) or pretreated for  1 h with 300 #M ATA (lanes 3 
and 4) and then incubated for further 12 h with 1.5/zg/ml anti- 
APO-1 (lanes 2 and 4). After lysis of the cells, DNA was extracted 
with phenol-chloroform-isoamylalcohol, precipitated  by ethanol, 
and dissolved in TE buffer with 0.1 mg/ml RNAse A. DNA frag- 
mentation was analyzed on a 1.8 % agarose gel in the presence of 
ethidium bromide.  (B) Cytotoxicity assay: cells were seeded at 3 
x  104/100/~l in 96-well plates.  12 h later 300/zM ATA or medium 
were added in a 50/zl vol. Following 1 h of further incubation, cells 
were treated with 1.5/~g/ml anti-APO-1 in the presence of 1/zg/ml 
actinomycin D. Cell survival was determined after 12 h by staining 
with crystal violet. Values represent the mean of triplicates +  SEM 
out of three experiments. 
clease activation efficiently prevented DNA degradation, but 
had no protective effect on cell viability. 
In conclusion, these experiments demonstrate that DNA 
fragmentation is not the critical event in apoptosis induced 
by the physiological inducer APO-1/Fas or the nonphysiolog- 
ical oxidant menadione. Whether this observation also holds 
true for apoptotic events induced by other initiators of apop- 
tosis remains to be established. At least TNF-mediated cyto- 
toxic  effects  cannot  be  prevented  by  inhibitors  of  en- 
donuclease in L929 cells (29). It has been reported that ATA 
can  inhibit  endonuclease  activity  as  well  as  cell  death  in 
some instances (17).  It should be noted, however, that ATA 
also interferes with protein synthesis (15) and thereby may 
affect those forms of apoptosis that require gene induction. 
Our observations concur with a recent report showing that 
in dexamethasone-treated thymocytes zinc ions completely 
inhibited endonuclease activity, but did not rescue these cells 
from corticoid-induced cell death (3).  Consistent with this, 
it has been described that cytotoxic T cell-mediated apopto- 
sis was also induced in fibroblast clones lacking detectable 
endonuclease activity (35).  Thus, the present study reveals 
that DNA degradation may be characteristic but not neces- 
sary  for  the  sequence  of  events  leading  to  apoptosis. 
Nonetheless, DNA degradation may facilitate disintegration 
of the cell and thereby support phagocytic removal of dead 
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Note Added in Proof. Daring typesetting of  this manuscript a study appeared 
showing  that staurosporine-induced apoptosis can also be seen in cytoplasts 
derived from a  fibroblast and oligodendrocyte cell line.  (Jacobson et al. 
1994.  EMBO l'Eur. Mol.  Biol.  Organ.] J.  13:1899-1910.) 
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